Última Hora: "TEIMA Alentejo SW apresenta nova ala - Publituris" Tue, 23 May 2017 10:03:53 GMT   "Altice anuncia o fim dass marcas PT e MEO até junho de 2018 - RTP" Tue, 23 May 2017 14:30:51 GMT    "Heranças, cartilhas e os louros pela descida do défice - Expresso" Tue, 23 May 2017 17:02:38 GMT    "Já pode voar para Buenos Aires, Havana ou Nova Iorque pela Ryanair - TVI24" Tue, 23 May 2017 19:27:13 GMT    "AHRESP saúda isenção de imposto de selo nos pagamentos com cartões - Jornal de Negócios - Portugal" Tue, 23 May 2017 15:47:00 GMT    "Centeno dispensa condições mais vantajosas para pagar empréstimos europeus - Jornal de Negócios - Portugal" Tue, 23 May 2017 13:07:42 GMT    "Sérgio Monteiro: Sem troca de obrigações não há venda. Mas há um plano B - Expresso" Tue, 23 May 2017 18:59:00 GMT    "Institucionais europeus compram dívida hipotecária do BCP - Jornal de Negócios - Portugal" Tue, 23 May 2017 17:41:58 GMT    "Portugal tem 30 pedidos de prospecção e pesquisa de lítio - Público.pt" Tue, 23 May 2017 06:16:09 GMT    "Comprou um anel numa feira e, 30 anos depois, descobriu que a joia vale uma fortuna - Visão" Mon, 22 May 2017 11:32:13 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Procure análises técnicas no nosso fórum aqui: Análises Técnicas
Nota: Os dados após 2009-10-29 são ainda temporários e poderão por isso ter o valor de Abertura errado até nova actualização...
Mudar para Gráfico Estático de Sepracor Inc.

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases ...
PR Newswire (press release)
Those defendants include Allergan, Inc., Amgen, Inc., Bradley Pharmaceuticals, Inc., Eisai, Inc., Mallincrodt, Inc., Novo Nordisk, Inc., Reliant Pharmaceuticals, Inc., Sepracor, Inc., and Upsher-Smith Laboratories, Inc. The settlement with Genzyme ...

e mais »

Psychiatric Implications of Neurological Disorders: May 2017
Healio
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...


Edited Transcript of FLKS earnings conference call or presentation 3-May-17 12:45pm GMT
Yahoo Finance
Elizabeth Woo, Flex Pharma, Inc. - Senior VP, IR and Corporate Communications [2] ... With their successful time together at Sepracor, Bill and Tom are a great team to rapidly advance FLX-787 in MS, ALS and Charcot-Marie-Tooth. We have multiple shots ...

e mais »

InvestorGuide

Cynapsus Therapeutics (CYNA) Stock Doubles on Sunovion Buyout
InvestorGuide
Shares of Cynapsus Therapeutics Inc. (CYNA) were trading up +21.44 or +116.78 percent to $39.80 per share in Thursday's premarket after news broke late yesterday that it would be acquired by Sunovion Pharmaceuticals Inc. Cynapsus Therapeutics stock ...

e mais »

Agilis Biotherapeutics Expands Commercial, Medical Teams
Business Wire (press release)
BUSINESS WIRE)--Agilis Biotherapeutics, Inc. (Agilis), a biotechnology company advancing innovative gene therapy products for the treatment of rare genetic diseases that affect the central nervous system (CNS), announced today that the Company has ...

e mais »

miRagen Therapeutics Expands Executive Leadership Team
Business Wire (press release)
From 1996 to 2002, Dr. Rubin held various roles with Sepracor, Inc., where he served as Senior Vice President, Development, and later as Executive Vice President, Research & Development. While at Sepracor he led the development of Sepracor's internally ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Business Wire (press release)
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with severe neurological diseases, today announced the appointment of William K. McVicar, Ph.D., as President of Research and Development. ... ?With ...

e mais »

Rewire

Religious Imposition Proponents Find an Ally in the White House
Rewire
Stirrup worked as a senior legislative adviser at Venable LLP from 2003 to 2008. The firm's clients between those years included AstraZeneca Pharmaceuticals, Sepracor Inc, and the National Association of Spine Specialists. Another hire, Anna Pilato, is ...


TheChronicleHerald.ca (registration)

PEI's BioVectra buys former Sepracor plant in Windsor
TheChronicleHerald.ca (registration)
A Charlottetown drug manufacturer has acquired a mothballed Windsor pharmaceutical plant and plans to reopen the facility in early 2016. BioVectra Inc. purchased the former Sepracor Canada (Nova Scotia) Ltd. facility in May. The Sepracor operation ...
Charlottetown's BioVectra expanding, setting up in WindsorHants Journal

todos os 5 artigos de notícias »

Sunovion Celebrates Five-Year Anniversary Milestone
Business Wire (press release)
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary. Sunovion was established in October 2010 following the integration of Sepracor Inc. and Dainippon ...

e mais »

POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Business Wire (press release)
Prior to joining Sepracor, Mr. Adams was President and Chief Executive Officer of Kos Pharmaceuticals, Inc. until its acquisition by Abbott Laboratories. Mr. Adams has also held general management and senior international and national marketing ...

e mais »

PMLiVE

Astellas appoints ethics and compliance and US legal leaders
PMLiVE
Wanda brings over 20 years of experience in the pharmaceutical industry, having held senior leadership positions at Schering-Plough and Sepracor Inc, a US-based biopharmaceutical company. Prior to joining Astellas as deputy general counsel and head of ...


Reuters

Dainippon to buy US drug firm Sepracor for $2.6 billion
Reuters
BOSTON/TOKYO Dainippon Sumitomo Pharma Co Ltd agreed on Thursday to buy U.S. drugmaker Sepracor Inc for $2.6 billion, giving the Japanese firm a big, local sales force in the world's largest drugs market. The deal is the latest in a string of overseas ...
Drugmaker Sepracor Accepts $2.6B Buyout Offer from Japan's DainipponXconomy
Another Japanese Drugmaker Makes Another Foreign AcquisitionWall Street Journal Blogs (blog)

todos os 485 artigos de notícias »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc. 


Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters